New Extramural Funding

Updated: May 16, 2018

Following is a list of the most recently announced cancer-focused extramural funding opportunities. Please refer to our Upcoming Funding page for additional funding opportunities.

 

National Institutes of Health

Innovative Research in Cancer Nanotechnology (IRCN) (R01) — Application Deadline: 5/23/18

National Cancer Institute Youth Enjoy Science Research Education Program (R25) — Application Deadline: 5/25/18

Cancer Research Education Grants Program to Promote Diversity – Courses for Skills Development (R25) — Application Deadline: 5/25/18

Cancer Research Education Grants Program to Promote Diversity – Research Experiences (R25) — Application Deadline: 5/25/18

Research Answers to National Cancer Institute’s (NCI) Provocative Questions (R01 Clinical Trial Optional) — LOI Deadline: 5/29/18   Application Deadline: 6/29/18

Research Answers to National Cancer Institute’s (NCI) Provocative Questions (R21 Clinical Trials Optional) — LOI Deadline: 5/29/18   Application Deadline: 6/29/18

Perception and Cognition Research to Inform Cancer Image Interpretation — Application Deadline: 5/30/18

Perception and Cognition Research to Inform Cancer Image Interpretation — Application Deadline: 5/30/18

Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional) — Application Deadline: 6/5/18

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)—  Application Deadline: 6/5/18

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01) — Application Deadline: 6/5/18

Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01) — Application Deadline: 6/5/18

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) — Application Deadline: 6/5/18

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) — Application Deadline: 6/5/18

Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) — Application Deadline: 6/5/18

Mechanisms of Alcohol-associated Cancers (R01) — Application Deadline: 6/5/18

Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the ‘epitranscriptome’) in Cancer Biology (R21) — Application Deadline: 6/5/18

Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) — Application Deadline: 6/5/18

Education and Health: New Frontiers (R01) — Application Deadline: 6/5/18

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) — Application Deadline: 6/5/18

Partnership for Aging and Cancer Research (U01 Clinical Trial Not Allowed) — Application Deadline: 6/8/18

Imaging and Biomarkers for Early Detection of Aggressive Cancer (U01) — LOI Deadline: 6/10/18   Application Deadline: 7/10/18

Innovative Approaches to Studying Cancer Communication in the New Media Environment — Application Deadline: 6/13/18

U.S. Tobacco Control Policies to Reduce Health Disparities — Application Deadline: 6/13/18

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) — Application Deadline: 6/16/18

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21) — Application Deadline: 6/16/18

Exploratory Grants in Cancer Epidemiology and Genomics Research (R21) — Application Deadline: 6/16/18

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) — Application Deadline: 6/16/18

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21) — Application Deadline: 6/16/18

Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) — Application Deadline: 6/16/18

Mechanisms of Alcohol-associated Cancers (R21) — Application Deadline: 6/16/18

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) — Application Deadline: 6/19/18

Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) — Application Deadline: 6/19/18

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research — Application Deadline: 6/27/18

Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the Drug Resistance and Sensitivity Network (DRSN)(Admin Supp Clinical Trial Not Allowed) — Application Deadline: 6/30/18

Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the Drug Resistance and Sensitivity Network (DRSN)(Admin Supp Clinical Trial Not Allowed) — Application Deadline: 6/30/18

 

 

Genentech & Bonnie J. Addario Lung Cancer Foundation

Accelerating Evidence into Practice Through Shared Decision Making: A National Call to Action — LOI Deadline: 5/2218

 

Hematology/Oncology Pharmacy Association

Early Career Research Grant — LOI Deadline: 5/25/18

Research Awards — LOI Deadline: 5/25/18

 

Pfizer

Advances in Immuno-Oncology — LOI Deadline: 5/31/18

 

Alex’s Lemonade Stand

A Awards — Application Deadline: 5/21/18

Reach Awards — Application Deadline: 5/21/18

 

Multiple Myeloma Research Foundation

Research Grants — Application Deadline: 5/25/18

 

Department of Defense – Congressionally Directed Medical Research Programs (CDMRP)

Breast Cancer Research Program: Breakthrough Award Levels 1 and 2 — Application Deadline: 5/30/18

Breast Cancer Research Program: Breakthrough Fellowship Award — Application Deadline: 5/30/18

Breast Cancer Research Program: Era of Hope Scholar Award — Application Deadline: 5/30/18

Lung Cancer Research Program: Idea Development Award — LOI Deadline: 6/26/18

Lung Cancer Research Program: Investigator-Initiated Translational Research Award — LOI Deadline: 6/26/18

Lung Cancer Research Program: Translational Research Partnership Award — LOI Deadline: 6/26/18

 

The Mark Foundation for Cancer Research

Emerging Leader Awards — Application Deadline: 6/4/18